Company intelligence / Profile preview

Cardima

United States

Ownership: Private
Development stage: Other

Overview

Cardima has developed diagnostic and ablation catheter systems for atrial fibrillation treatment. The REVELATION® Series of ablation catheters with the INTELLITEMP® EP Energy Management Device has received CE mark approval and is marketed in Europe. All Cardima devices have received CE mark approval and FDA 510(k) clearance.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Cardima.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardima.

Explore the full profile